Nathanael Fillmore, PhD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Fillmore leads a group using clinical, genomic, and imaging data, particularly from the national VA system, together with artificial intelligence and statistical methods, in research to improve patient care. They are also working on software and methodological improvements to support these efforts.

Publications

  • Published 5/29/2026

    Stabellini N, Nahle T, Shah V, Kollapaneni SS, Makram OM, Cullen J, Weintraub NL, Kunhiraman HH, Swami U, Mahmoudi M, Fillmore N, Garraway IP, Leong D, Pinthus J, Shanahan J, Montero AJ, Agarwal N, Guha A. Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular Risk. JCO Oncol Pract. 2026 May 29; OP2600131. PMID: 42214056.

    Read at: PubMed

  • Published 5/25/2026

    Kim DY, Swetter SM, Huhmann L, Ferguson JM, Breglio K, Spence AC, Wheless L, Brophy MT, Do NV, Fillmore N, Hartman RI. Sentinel Lymph Node Biopsy Utilization and Positivity in Veterans with Cutaneous Melanoma: A Comparative Analysis of the VA Cancer Registry and the SEER Program. J Am Acad Dermatol. 2026 May 25. PMID: 42190751.

    Read at: PubMed

  • Published 5/18/2026

    He T, Zheng C, La J, Pham D, Jafari O, Strampe J, Dulberger K, Ramos-Cejudo J, Gaziano JM, Do NV, Chitalia V, Ravid K, Li A, Fillmore NR. A deep learning model to dynamically predict cancer-associated thromboembolism in large-scale healthcare systems. NPJ Digit Med. 2026 May 18. PMID: 42151458.

    Read at: PubMed

  • Published 4/22/2026

    Grubber JM, Oboho IK, Swinnerton KN, Feldman TC, Do NV, Fillmore NR, Branch-Elliman W, Monach PA. Severe outcomes of individual or multiple respiratory viral infections in a large national healthcare system, 2022-2023. Front Public Health. 2026; 14:1808528. PMID: 42100533.

    Read at: PubMed

  • Published 4/2/2026

    Ryu J, La J, Patell R, Li A, Do N, Brophy M, Fillmore N, Zwicker JI. Survival assessment of warfarin and international normalized ratio exposure in cancer-associated venous thromboembolism: Veterans Affairs healthcare system-based analysis. Haematologica. 2026 Apr 02. PMID: 41924910.

    Read at: PubMed

Education

  • University of Wisconsin Madison, PhD
  • University of Wisconsin Madison, MS
  • Carleton College, BA